BREAKING: CDC Stops Johnson And Johnson Vaccine Over DEADLY Side Effect!
Got to tell you folks, some things in this world are all about planning and preparation. When I moved my entire family from Pennsylvania to Florida five years ago, my wife and I planned for almost a year and had the money to move six months before the big day was scheduled. A year of planning for four people.
I have a friend who works in the research and design lab for a fast-food chain, and sometime about a year ago, they unveiled a new dipping sauce for their chicken nuggets. They brought me over a small batch to try a few days before it got out to everyone and I asked how long they had been working on it. They told me at the very least three years before they got to taste tests.
Now, yes, everyone wants a vaccine for COVID. I’m not gonna try to lie to you and say that something like this just doesn’t exist. You can leave that for people with much thicker tinfoil hats than mine. All I am saying is that if you are giving someone a vaccine that took less time to go from start to finish than a farmer’s crop of wheat for the year, then maybe we shouldn’t be so surprised when people start bursting into a million pieces…
The Food and Drug Administration (FDA) together with the Centers for Disease Control and Prevention (CDC) is recommending a pause in the rollout of the Johnson & Johnson COVID-19 vaccine after several instances of severe blood clots in recipients.
According to the FDA, there have been six reported cases of the rare and severe type of blood clot in over 6.8 million Johnson & Johnson COVID-19 vaccine recipients.
“Right now, these adverse events appear to be extremely rare,” the agency said on Twitter. “Treatment of this specific type of blood clot is different from the treatment that might typically be administered. CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.”
However, until that review is completed, the FDA is “recommending this pause.”
In a statement provided to Fox News, Johnson & Johnson said the “safety and well-being of people who use our products” remains the company’s number one priority, and that it was aware of an “extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine.”